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IRP1 [iron regulatory protein (IRP) 1] is a bifunctional protein with mutually exclusive end-states. In one mode
of operation, IRP1 binds iron-responsive element (IRE) stem–loops in messenger RNAs encoding proteins of
iron metabolism to control their rate of translation. In its other mode, IRP1 serves as cytoplasmic aconitase to
correlate iron availability with the energy and oxidative stress status of the cell. IRP1/IRE binding occurs
through two separate interfaces, which together contribute about two-dozen hydrogen bonds. Five amino
acids make base-specific contacts and are expected to contribute significantly to binding affinity and
specificity of this protein:RNA interaction. In this mutagenesis study, each of the five base-specific amino
acids was changed to alter binding at each site. Analysis of IRE binding affinity and translational repression
activity of the resulting IRP1 mutants showed that four of the five contact points contribute uniquely to the
overall binding affinity of the IRP1:IRE interaction, while one site was found to be unimportant. The
stronger-than-expected effect on binding affinity of mutations at Lys379 and Ser681, residues that make
contact with the conserved nucleotides G16 and C8, respectively, identified them as particularly critical for
providing specificity and stability to IRP1:IRE complex formation. We also show that even though the
base-specific RNA-binding residues are not part of the aconitase active site, their substitutions can affect the
aconitase activity of holo-IRP1, positively or negatively.
© 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.Introduction
Iron is an essential nutrient but, in excess, can lead
to the formation of harmful free radicals. Therefore, a
diverse set of cellular sensory and regulatory
mechanisms is in place to control iron metabolism.
Iron regulatory proteins (IRPs) are central to the
cell's protective system, where they post-transcrip-
tionally regulate other proteins responsible for
cellular iron homeostasis. IRPs achieve this control
by binding to iron-responsive elements (IREs),
~30-nucleotide-long stem–loops in the 5′ or 3′
untranslated regions of the corresponding messen-
ger RNAs (mRNAs). IRPs do not possess common
RNA binding motifs but still recognize and bind a
variety of IRE stem–loops with picomolar affinity.
The characteristic secondary structure adopted by
IRP-bound IREs presents two separate regions for
recognition: a terminal loop and a mid-stem bulge
[1,2]. The five conserved nucleotides CAGUG ofuthors. Published by Elsevier Ltd.Open access ueach IRE sequence (nucleotides 14–18 in our
numbering) form the terminal pseudotriloop of the
structure, with the central AGU triplet at the apex.
The other important IRE feature is the conserved C8
bulge in the middle of the stem. The C8 hinge region
forms multiple interactions when bound to IRP1. The
IRE stem is divided into the upper helix between the
C8 bulge and the terminal loop and the lower helix
below the hinge.
Two IRPs are known: IRP1 and IRP2. They are
highly homologous (~60% identity) and have similar
overall affinities for IREs [3,4] but with distinct IRE
recognition abilities [5–7]. The two IRPs are con-
served in 15 of the 22 amino acids responsible for
IRE binding. The variations may contribute to the
differences in IRE recognition by these two proteins.
During excess cellular iron levels, IRP1 becomes a
cytosolic (c-) aconitase after acquiring a [4Fe–4S]
cluster and looses RNA binding ability [8], while
IRP2 undergoes degradation [9]. The unligandedJ. Mol. Biol. (2013) 425, 3301–3310nder CC BY-NC-ND license.
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[8,10]. Apo-IRP1 undergoes proteasomal degrada-
tion when iron–sulfur cluster synthesis is defective,
but with lower efficiency as compared to IRP2 [11].
IRP1 employs two known sites for IRE binding: the
terminal loop-binding cavity and the pocket for the
bulged C8 [1,2]. Each site involves all types of
protein:RNA interactions, with hydrogen bonding
being prominent. While hydrogen bonds do not
constitute the strongest interactions between protein
and RNA, they are responsible for binding specificity
[12]. Early mutagenic studies of IRP1 provided
insights regarding IRP:IRE interactions and impor-
tantly demonstrated the overlap of amino acids
involved in RNA binding and aconitase active-site
formation [13–19]. In the recent crystal structures of
IRP1:IRE complexes, we identified many of the
contacts for IRP1:IRE binding [1,2]. In this study, we
focus on the five IRP1 residues—Arg269, Ser371,
Lys379, Ser681, and Asn685—thought to determineFig. 1. The five IRP1 residues that form base-specific hydrog
IRE (cartoon) is shown as bound to the IRP1 protein (solvent-a
Asn685 are visible (yellow), while Ser371 and Ser681 are hidd
shown by insets. Note that these residues are different from
Arg699, and Arg780) previously studied based on homology mthe specificity of binding (Fig. 1) and investigate their
contributions to complex stability and aconitase
activity through site-specific mutagenesis of each
residue.Results
Rationale for construction of IRP1 mutants
In order to gain insight into the contribution of the
five base-specific bonds to overall affinity and
specificity of IRP1:IRE interaction, as well as to
begin understanding the contribution of the individual
binding interfaces to affinity of interaction, we
mutated each of the base-specific contact residues
to eliminate hydrogen bonding with the RNA base.
Three mutations were made in the terminal loop-
binding cavity. First, mutation of Arg269 to alanineen bonds to the IRE RNA in the IRP1:IRE complexes. The
ccessible surface). The amino acids Arg269, Lys379, and
en from view. Details of the five base-specific contacts are
the four aconitase active-site arginines (Arg536, Arg541,
odeling [14–16].
Fig. 2. Effect of IRP1 mutations on IRP-dependent
translational repression. Luciferase activity measured in
extracts of yeast strain AS4742 expressing the indicated
IRP1. Cells were grown on SD-His-Ura synthetic media
and harvested at logarithmic growth. The means and
standard deviations of six independent experiments are
shown. Luciferase activity is activity per total protein of
extract. IRP1 expression levels were determined using
immunoblotting with an antibody to a C-Myc epitope tag.
Antibodies to PGK protein, one of the cell extract
components, were used to monitor equal loading of
extracts. Shown is one preparation out of six.
3303Iron Regulatory Protein 1 Recognitionshould completely eliminate the hydrogen bond
between the guanidinium group and O4 of U17
(Fig. 1a). Second, Ser371 was mutated to alanine
and to aspartate: S371A should remove the bond
between the hydroxyl of Ser371 and the N6 amino
group of A15 (Fig. 1b), while the S371D substitution
adds charge, bulk, and potential for steric clash in the
loop-binding cavity. Third, Lys379 was mutated to
asparagine and arginine to eliminate or alter the bond
to O6 and N7 of G16 of the terminal loop (Fig. 1c).
In the C8 binding pocket, Ser681 was changed to
alanine, which is expected to eliminate bonding of its
hydroxyl with N4 of the C8 base (Fig. 1d). Moreover,
Asn685, which was observed to form a base-specific
hydrogen bond with N2 of the G26 base in the minor
groove of the lower helix of ferritin IREs (Fig. 1e),
was mutated to alanine and serine, which lack the
capacity or are too short to make such a bond to the
IRE.
Translational repression by IRP1 mutants
As a first step toward understanding the impor-
tance of each residue for IRP1 function, each mutant
IRP1 was evaluated for ability to repress translation
of an IRE-containing reporter mRNA in yeast as an
initial interrogation of IRE-binding function. A chime-
ric IRE-luciferase gene under the transcriptional
direction of the yeast ADH1 promoter served as
the reporter and was integrated into the genome,
creating strain AS4742 (see Experimental Proce-
dures). Expression of wild-type IRP1 in AS4742
reduced luciferase expression by approximately
70% relative to the strain lacking any IRP1 (Fig. 2).
Expression of each of the IRP1 mutants in this strain
caused reduction in luciferase level, suggesting that
each mutant protein retained some ability to bind IRE
and repress translation of the IRE-luciferase mRNA.
A similar level of repression of luciferase to that seen
with wild-type IRP1 was observed upon expression
of the R269A, K379R, N685A, and N685S IRP1
mutants, indicating comparable translational repres-
sion ability under the conditions used. The other
IRP1 mutants (S371A, S371D, K379N, and S681A)
were noticeably poorer at repression of luciferase in
this system (Fig. 2). Importantly, there were compa-
rable levels of wild type and each of the mutant IRP1
proteins in these yeast, indicating that the differential
repression seen was most likely due to differential
IRE binding ability of the IRP1 mutants.
IRE binding and Kd determinations for IRP1
mutants
To have a more quantitative analysis of IRE
binding by these IRP1 mutant proteins, we used
nitrocellulose filter-binding assays to determine
dissociation constants (Kd) of the IRP1:IRE interac-
tions [20,21]. Representative binding curves for thewild-type and IRP1 mutants are shown in Supple-
mental Fig. 1. The Kd for the complex of ferritin L IRE
with wild-type IRP1 was measured at 17.6 ± 4.6 pM,
which is in agreement with earlier published obser-
vations [20]. The Kd values for the N685A and
N685S IRP1 mutants were equivalent to that of wild-
type IRP1 (Table 1), indicating that Asn685 contrib-
utes little to the overall affinity of IRP1 interaction
with human ferritin L IRE. The remaining IRP1
mutants fall into two categories based on the effect
of the change on IRE binding affinity. Category 1,
which includes the R269A, S371A, and K379R
mutants, showed a decrease in IRE binding affinity
around 10-fold (Table 1). Category 2, which includes
the S371D, K379N, and S681A mutants, showed
more than a 100-fold decrease in IRE binding affinity
(Table 1). Binding of each of the category 2 mutants
with human L-ferritin IRE was weak, increasing the
uncertainty in the Kd values obtained with the
nitrocellulose filter-binding assays. A significantly
lower binding affinity for these IRP1 mutations was
also suggested by the weaker translational repres-
sion observed in the yeast system (Fig. 2 and
Supplemental Fig. 2). Thus, each of these mutations
in IRP1 had a greater effect on IRE binding than
would be predicted from simply a loss of a single
hydrogen bond, and non-additive effects appear to
be in play.
Table 1. Kd and Krel values of WT and mutant IRP1 for
ferritin L IRE
IRP1 expressed Kd (pM) ± SD Krel
WT 17.6 ± 5 1.0
R269A 141. ± 49 8.0
S371A 212. ± 21 12.0
S371D 2400. ± 1200 N100
K379N 2900. ± 1300 N100
K379R 164. ± 60 9.3
S681A 3500. ± 1200 N100
N685A 10.6 ± 3 0.6
N685S 17.7 ± 6 1.0
3304 Iron Regulatory Protein 1 RecognitionIntracellular aconitase function of IRP1 mutants
The IRP1 mutants were examined for the alternate
activity as an aconitase to gain insight into whether
the mutations had general effects on protein
function. To test for intracellular aconitase function,
we investigated the ability of each IRP1 mutant to
rescue aconitase-deficient (aco-1) yeast from gluta-
mate auxotrophy. Yeast lacking aconitase cannot
synthesize glutamate due to an inability to generate
α-ketoglutarate, a precursor for glutamate synthesis,
via the Kreb's cycle [22]. IRP1 can provide c-
aconitase activity and restore glutamate prototrophy
and growth of aco1 yeast on glutamate-free media
[23]. Each IRP1 mutant was transformed into the
aconitase-deficient 0615d strain, and the resulting
transformants were tested for growth on glutamate-
free agar media (Fig. 3). All of the IRP1 mutants
supported growth of this strain on glutamate-free
media, although there were differences in the
strength of growth. This indicated that each mutant
was a functional aconitase within the yeast cell.
The aconitase activity from the IRP1 mutants was
also examined in extracts of these yeasts. Activity
was detected for all of the IRP1 mutants, although
like growth, aconitase activity was variable (Fig. 4).
In fact, growth rate in liquid glutamate-free media
(Supplemental Fig. 3) correlated quite well with
aconitase activity detected for IRP1 mutants (Fig. 5).
Reconstitution of aconitase activity in IRP1
mutants
To determine the effect of these IRP1mutations on
efficiency of aconitase function, we subjected each
mutant protein in crude yeast extract to conditions for
chemical FeS cluster reconstitution followed by
analysis of aconitase activity [24]. Reconstitution of
wild-type IRP1 under these conditions resulted in
complete recovery of wild-type aconitase activity, at
approximately 33 U/mg IRP1, which is in good
agreement with published data for recovered wild-
type activity [6] (Fig. 6). Cluster reconstitution of
each of the IRP1 mutants restored significant
aconitase activity as well (Fig. 6). Interestingly, theR269A, S371A, N685A, and N685S IRP1 mutants
gave more than 2-fold higher aconitase specific
activity than wild type, suggesting that these
mutations might actually increase enzyme efficien-
cy. The aconitase specific activity obtained for the
K379N mutant was equivalent to wild-type protein,
while the S371D, K379R, and S681A mutants gave
a slightly reduced specific activity. However, it is
important to note that the aconitase specific activity
for these IRP1 mutants was within 2-fold of wild-type
activity, whereas the negative effect on IRE binding
of all but the Asn685 mutations was significantly
greater.Discussion
The highly specific binding of IREs by IRP1 occurs
through two binding interfaces that combine to give
one of the tightest protein:nucleic acid interactions in
nature. Approximately two dozen hydrogen bonds
identified in the crystal structure of the IRP1:ferritin
IRE complex and distributed between the two
binding interfaces support this interaction, but only
five of the putative bonds are sequence specific.
Here, through site-specific mutagenesis and func-
tional analysis of mutant proteins, we show that
mutation of four of the five amino acid residues—
Arg269, Ser371, Lys379, and Ser681—significantly
impaired interaction of IRP1 with ferritin IRE, con-
firming the importance of these bonds for IRP1:IRE
recognition. Mutation at these sites caused reduction
in binding affinity that ranged from 8-fold to more
than 100-fold (Table 1). Thus, each of these contacts
likely plays an important role in the specificity of the
IRP1:IRE interaction, as well as to the overall affinity.
Mutation at the fifth site, Asn685, did not alter
ferritin IRE binding (Table 1). We previously ob-
served that Asn685 forms a base-specific hydrogen
bond with G26 atom N2 in the IRP1:ferritin H IRE
complex, made possible by the wobble base-pair
G26:U5 that is unique to ferritin IREs [1]. However,
the geometry of this putative bond was not optimal
(Fig. 1e). The results reported here indicate that a
bond between Asn685 and G26, if it exists, does not
contribute to the overall affinity of IRP1:ferritin IRE
interaction (Table 1). This is consistent with the
observations of Goforth et al. that mutation of ferritin
IRE to eliminate this contact had little to no effect on
protein:RNA binding [7].
Of the two interfaces used for the IRP1:IRE
interactions—the IRP1 cavity with terminal loop
versus the IRP1 pocket with C8 bulge—the former
is more complex, with greater size and more
extensive bonding. Three amino acid–nucleotide
base-specific contacts are confined to the terminal
loop-binding cavity: Arg269 with U17, Ser371 with
A15, and Lys379 with G16 (Fig. 1a–c). In the IRP1:
IRE complexes, Arg269 interacts with U17, the
Fig. 3. Ability of IRP1 mutants to rescue aco-1 yeast strains from glutamate auxotrophy. Strain 0651d expressing the
indicated IRP1 was grown to mid-logarithmic phase in SD-Ura, washed twice with sterile H2O, and then spotted as 10-μl
aliquots of serial dilutions containing from 102 to 105 cells on SD-Ura with or without glutamate as indicated.
3305Iron Regulatory Protein 1 Recognitiontopmost stacked base of the IRE stem, where its
guanidinium group has a hydrogen bond to the
exposed O4 of the uracil base (Fig. 1a). The
Arg269A substitution eliminated this base-specific
interaction and reduced IRP1:IRE binding by 8-fold
(Table 1). The magnitude of the reduction seems
large given that the Arg269–U17 interaction issolvent accessible and that the side chain has
access to other conformations. Probably, the addi-
tional bond to the neighboring (and also IRP
invariant) Glu302 carboxyl stabilizes this interaction,
while the stacking of Glu302 on top of U17 also
contributes to the high IRP:IRE affinity. U17 is not
invariant among naturally occurring IRE sequences.
Fig. 4. Aconitase activity of IRP1 mutants. Aconitase
specific activity of the indicated IRP1 mutants in crude
yeast cytoplasmic extracts. Error bars indicate standard
deviations for three experiments. IRP1 expression levels
were determined using immunoblotting with an antibody to
a C-Myc epitope tag. Antibodies to PGK protein, one of the
cell extract components, were used to monitor equal
loading of extracts. Shown is one preparation out of five.
Fig. 6. Aconitase activity of IRP1 mutants after iron–
sulfur cluster reconstitution. Error bars indicate standard
deviations for three experiments.
3306 Iron Regulatory Protein 1 RecognitionFor example, it is A17 in the 3′ IRE that regulates
translation of MRCKα, a serine/threonine kinase
involved in cytoskeletal reorganization [25]. The
CAGAG terminal loop sequence of the MRCKα
IRE was originally reported to have the same or
possibly higher binding affinity as the wild-type
CAGUG [25]. Simple model building shows that the
terminal loop and binding cavity can accommodate
the uridine-to-adenine switch with no clashes.
However, the introduced extracyclic amine (N6)
would be closest to the guanidinium of Arg269,
which, contrary to above, should reduce the bondingFig. 5. Correlation of aconitase-dependent growth rate
with aconitase activity for wild-type and mutated IRP1.
R2 = 0.64. Growth rates were calculated from the growth
curves shown in Supplemental Fig. 3.potential. This discrepancy is not understood, but
perhaps other elements of the IRP1:MRCKα IRE
interaction can compensate. In addition to the U17A
variant in the MRCKα IRE, there are U17G and
U17C substitutions in the TfR1 A IREs from two
species of fish and chicken [26]. If TfR1 A IREs are
truly functional [27], then sequence variety at this
position in the IRE family must be accommodated by
other means.
The Ser371 hydroxyl has a hydrogen bond with
the N6 amino group of the fully extended A15 of the
IRE terminal loop in the IRP1:IRE complexes, and
possibly with N7 (Fig. 1b). Conservation of the
Ser371-to-A15 interaction appears absolute: Ser371
is invariant in all IRPs investigated, and there are no
known normally functioning IRE variants at position
15 of the apical loop. The S371A substitution in IRP1
eliminates the serine hydroxyl and decreases the
binding strength 12-fold, while an aspartate substi-
tution (S371D) has a stronger inhibitory effect on
binding affinity, decreasing it by more than 100-fold
(Table 1). These two mutations thus demonstrate
both the importance of the hydrogen bonds and the
consequence of charge and steric clash at that site.
For the S371D mutation, there is simply no space to
accommodate the added aspartate charge and bulk;
thus, A15 would not be able to fully extend into the
cavity it normally occupies in the IRP1:IRE complex.
It is likely that the charge change from the S371D
substitution also disrupts the neighboring interac-
tions of Lys379 with G16 (see below). There are two
spontaneous mutations at position 15 of human
ferritin IREs that present different pathophysiologies:
A15G and A15U [28]. In the first case, an A15G
transition in ferritin L IRE is responsible for the
heritable hypoferritinemia cataract syndrome
(HHCS) mutation known as Paris 1 [29]. The A15G
mutation reduced IRP1 affinity by ~200-fold as
3307Iron Regulatory Protein 1 Recognitionmeasured in IRE competition experiments [4]. An
amino-to-oxo switch at C6 of the purine eliminates
the only hydrogen donor to Ser371, similar in effect
to the S371A IRP1 substitution, but the ~200-fold
decrease in IRE affinity is roughly an order of
magnitude worse than the effect of the S371A
substitution measured here. The 2-amino group of
A15G may also contribute to the decrease. In the
second case, an A15U substitution in ferritin H
causes an iron overload disorder, which is heritable
as an autosomal dominant trait [30]. It was reported
to cause a 2-fold higher affinity for IRP1. Simple
modeling of the A15U transversion (assuming the
same stem–loop folding and stability) does not
suggest an increase in affinity between the intro-
duced O4 carbonyl and the S371 hydroxyl.
Lys379 of IRP1 binds to O6 and N7 of G16 in the
terminal loop-binding cavity in the IRP1:IRE com-
plexes (Fig. 1c). Our results with the K379R mutant
IRP1 showed a 9-fold decrease in the binding
strength to ferritin L IRE (Table 1). The K379R
substitution (which occurs naturally at the equivalent
position in IRP2) preserves the positive charge of the
residue but introduces the larger guanidinium group,
possibly creating strain on the interactions in the
terminal loop-binding cavity. This difference between
IRPs may contribute to the observed higher toler-
ance for variation at IRE position 17 for binding by
IRP2 [31]. The K379N substitution shows even
greater weakening (N100-fold) of the IRP1:IRE
interaction. Elimination of the positive charge on
residue 379 may affect binding of the entire terminal
loop, possibly by reducing the ability of IRP1 to
stabilize the IRE conformation that promotes high-
affinity interaction. An equivalent effect is seen with
the introduction of the negative charge in the S371D
substitution discussed above. As for spontaneous,
disease-causing HHCS mutations at position 16 of
IREs, the G16C substitution of the ferritin L IRE
known as Verona [32] causes the largest loss in IRP
affinity of all [4]. Clearly, the introduction of the C16
N4 amino group would completely eliminate attrac-
tive interaction with the Lys379 side chain.
The C8 bulge region may be the simpler of the two
IRP:IRE recognition interfaces because it involves
just one unpaired nucleotide. The pocket for C8 is
lined with many hydrogen bonding groups, and the
cytosine base forms hydrogen bonds with four of
them (Fig. 1d). However, three are through backbone
atoms and/or solvent: only Ser681 provides a
functional side chain, where the γ hydroxyl makes a
hydrogen bond with N4 of the deeply buried C8 base.
Elimination of that interaction by aS681A substitution
decreases the IRP1:IRE binding affinity bymore than
100-fold, an effect obviously far greater than removal
of a single hydrogen bond. Ser681 is absolutely
conserved in all IRP1 and IRP2 sequences. The
restricted volume of the pocket and complementarity
to C8 might dictate that any substitution at position8 would be unfavorable. Indeed, two independent
types of HHCS are caused by the naturally occurring
mutations C8U and C8A in the human ferritin L IRE
[33,34] (their IRP binding strengths have not been
determined). Oddly however, a C-to-G substitution at
position 8 is permissible in the IREs of sand worms,
sea squirts, crayfish, and shrimp [26] (their function-
alities are yet to be demonstrated). It is tempting to
assume that their IRP pockets evolved in parallel with
their IREs to accommodate the larger purine, but a
homology modeling experiment with the crayfish
IRP1 sequence (Pacifastacus leniusculus; 69%
identity with Homo sapiens) revealed total conserva-
tion in and around the binding pocket (K.W.V.,
unpublished results).
This is the first study to functionally define the IRP1
residues that form specific hydrogen bonds to the
IRE bases, analogous to the studies of the FeS
cluster-binding cysteine residues necessary for the
aconitase function [13,15]. Comparison of the crystal
structures of the IRP1:IRE complexes with c-
aconitase shows extensive overlap between the
IRE binding and aconitase active sites, with several
amino acid residues playing important roles in both
[1,35]. However, none of the residues that make
sequence-specific bonds with IRE are aconitase
active-site residues (Supplemental Fig. 4). Analysis
of aconitase function of mutant IRP1 by yeast growth
and in extracts showed all of the IRP1 mutants to be
functional aconitases (Figs. 3–6). Upon FeS cluster
reconstitution, the mutant c-aconitases gave specific
activities within 2-fold of wild type (Fig. 6). The
positive effects of some mutations on aconitase
activity were surprising, showing that the bifunction-
alities of IRP1 are more integrated than expected.
This is despite the fact that the residues in this study
are more than 15 Å from the c-aconitase FeS cluster
(Supplemental Figs. 4 and 5).
It is not yet possible to predict whether a particular
aconitase has dual IRE binding and aconitase
functions similar to those of mammals or functions
only as an aconitase. The IRP1 residues that make
contact with the IRE are mainly conserved in the IRP/
AcnA branch of the aconitase superfamily. One
exception is Lys379, which is primarily an arginine in
non-IRE-binding c-aconitases. As discussed above,
the equivalent residue is arginine in all known IRP2s
aswell. This suggests that amino acid residue identity,
while important, is not the sole determinant of function
as an IRE-binding protein. Nonetheless, Lys379 and
Ser681 appear to be particularly crucial to IRE binding
in that mutations of these residues cause the greatest
impairment of binding. Both G16 and C8 of the IRE,
the respective bonding sites for Lys379 and Ser681,
are fully extended and accommodated by the protein
in the complex [1,2]. It is intriguing to think that the key
features selected in the evolution of this high-affinity
protein:RNA regulatory system were the contacts that
stabilized the extended conformationof the conserved
3308 Iron Regulatory Protein 1 Recognitionnucleotides of the IRE, providing a level of selectivity
that would eventually mediate control of cellular iron
metabolism.
Experimental Procedures
IRP1 mutagenesis and expression in yeast
Site-specific mutagenesis of rabbit IRP1 was
performed using the Stratagene QuikChange II
Site-Directed Mutagenesis Kit following the manu-
facturer's recommended procedure. An identical set
of mutations was engineered in vectors designed to
express the protein with an N-terminal 6-His tag for
protein purification or with a C-terminal myc-epitope
tag for all other uses [36,37]. All mutations were
verified by DNA sequencing. Overexpression of
wild-type and mutant IRP1 and purification from
yeast was performed as described previously [36].
To assess aconitase function, we expressed IRP1
mutants in the aconitase-deficient 0615d Saccharo-
myces cerevisiae strain (MATa, ura3-52, trp1-Δ63,
his3-Δ200, aco1-1, ade2, IDP2up) [23,37]. To
assess the translational repression function of
mutant IRP1 in yeast, we constructed the strain
AS4742 by integrating an IRE-luciferase reporter
gene in which the firefly luciferase open reading
frame was fused to the human L-chain IRE
sequence under transcriptional direction of a mini-
mal ADH1 promoter [23] into the yeast genome at
the HIS3 locus of strain BY4742 (Open Biosystems).
All yeast transformations were performed using the
lithium acetate method [38]. Yeast were routinely
grown at 30 °C in synthetic dropout (SD) media
supplemented with 2% dextrose and lacking the
appropriate nutrient for selection and maintenance
of plasmids [39]. For testing aconitase function of
IRP1 mutants in yeast, growth analysis was per-
formed in SD lacking glutamate [37].
Yeast cytoplasmic extract preparation and
enzyme assays
Preparation of yeast cytoplasmic extracts, deter-
mination of total extract protein, protein immunoblot,
and enzyme assays were performed as described
elsewhere [23,37]. Standard aconitase activity
assay conditions consisted of 10.0 mM Tris–HCl
(pH 8.0) and 2.0 mM D/L-trisodium isocitrate. FeS
cluster reconstitution was performed chemically by
incubating yeast extracts containing IRP1 with
0.5 mM Fe(NH4)2(SO4)2, 0.5 mM Na2S, and 5 mM
DTT for 1 h at room temperature. Yeast extracts for
IRP1 expression analysis were prepared using the
post-alkaline method [40]. Western blot images were
quantified using Alpha Imager software and statis-
tically processed using GraphPad Prism software
(GraphPad Software, Inc.).IRP1:IRE affinity measurement
The affinity of each of the IRP1 mutant proteins for
human ferritin L IRE was determined using purified
proteins and nitrocellulose filter-binding assay [20].
His-tagged IRP1 was expressed and purified using a
Ni affinity column as described previously [36]. The
purity of each protein preparation was N95% as
determined by SDS-PAGE. Single-use aliquots in
20 mM Tris (pH 7.4), 100 mM KCl, 10% glycerol, and
5 mM DTT were stored at −80 °C at concentrations
from 20.6 to 42.9 μM. [32P]human L-ferritin IRE probe
was prepared from pTZM1 and used in nitrocellulose
filter-binding assays as described by Swenson et al.
[20]. The complex dissociation constant for each IRP1
variant was determined from RNA saturation curves
(1.3 pM to 15 nM) performed under equilibrium
conditions, where increasing amounts of radioactively
labeled IRE transcripts were added to constant
amounts of protein. Standard binding conditions
consisted of 50 mM Tris–HCl (pH 7.5), 40 mM KCl,
3 mM MgCl2, 1 mM DTT, 20 μg/ml bovine serum
albumin, and 66 μg/ml Escherichia coli tRNA. Re-
actionswere performed in triplicate at 37 °C for 20 min
and then passed through 24-mm nitrocellulose filters
(Millipore-HAWP), which had been pre-equilibrated
with binding buffer. Filters were immediately washed
with five volumes of ice-cold binding buffer. Average
time of washingwas 4 s. Filters were dried at 80 °C for
30 min and bound radioactivity was measured by
liquid scintillation. Data analysis and curve fitting were
performed using GraphPad Prism (GraphPad Soft-
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